...
首页> 外文期刊>American Journal of Physiology >AT_1 receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats
【24h】

AT_1 receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats

机译:AT_1受体激活调节血管紧张素II高血压大鼠肾小球前血管中CAT1,CAT2,精氨酸酶-1和DDAH2的mRNA表达

获取原文
获取原文并翻译 | 示例

摘要

Previously, we found increased expression of L-arginine metabolizing enzymes in both kidneys from two-kidney, one-clip (2K1C) hypertensive rats (Helle F, Hultstrom M, Skogstrand T, Palm F, Iversen BM. Am J Physiol Renal Physiol 296: F78-F86, 2009). In the present study, we investigate whether AT_1 receptor activation can induce the changes observed in 2K1C. Four groups of rats were infused with 80 ng/min ANG II or saline for 14 days and/or given 60 mg centre dot kg~(-1) centre dot day~(-1) losartan. Gene expression was studied in isolated preglomerular vessels by RT-PCR. Dose-responses to ANG II were studied in isolated preglomerular vessels with and without acute NOS inhibition [10~(-4)mol/l N~G-nitro-L-arginine methyl ester (L-NAME)]. Expressions of endothelial nitric oxide synthase (eNOS), caveolin-1, and arginase-2 were not changed by ANG II infusion. CAT1 (0.3 8 +- 0.07 to 0.73 +- 0.12, P < 0.05), CAT2 (1.14 +- 0.29 to 2.74 +- 0.48), DDAH2 (1.09 +- 0.27 to 2.3 +- 0.46), and arginase-1 (1.08 +- 0.17 ,to 1.82 +- 0.22) were increased in ANG II-infused rats. This was prevented by losartan treatment, which reduced the expression of eNOS (0.97 +- 0.26 to 0.37 +- 0.11 in controls; 0.8 +- 0.16 to 0.36 +- 0.1 in ANG II-infused rats) and caveolin-1 (2.49 +- 0.59 to 0.82 +- 0.24 in controls and 2.59 +- 0.61 to 1.1 +- 0.25 in ANG II-infused rats). ANG II (10~(-10) mol/l) caused vessels from ANG II-infused animals to contract to 53 +- 15% of baseline diameter and 90 +- 5% of baseline diameter in controls (P < 0.05) and was further enhanced by L-NAME to 4 +- 4% of baseline diameter (P < 0.05). In vivo losartan treatment reduced the reactivity of isolated vessels to 91 +- 2% of baseline in response to 10~(-7) mol/l ANG II compared with 82 +- 3% in controls (P < 0.05) and prevented the increased responsiveness caused by ANG II infusion. In conclusion, CAT1, CAT2, DDAH2, and arginase-1 expression in renal resistance vessels is regulated through the AT_1 receptor. This finding may be of direct importance for NOS and the regulation of preglomerular vascular function.
机译:以前,我们发现两肾一夹(2K1C)高血压大鼠(Helle F,Hultstrom M,Skogstrand T,Palm F,Iversen BM。Am J Physiol Renal Physiol 296)的两个肾脏中L-精氨酸代谢酶的表达增加:F78-F86,2009)。在本研究中,我们调查AT_1受体激活是否可以诱导2K1C中观察到的变化。给四组大鼠注入80 ng / min ANG II或生理盐水注入14天,和/或给予60 mg中心点kg〜(-1)中心点日〜(-1)氯沙坦。通过RT-PCR在分离的肾小球前血管中研究基因表达。研究了在有或没有急性NOS抑制作用的分离的肾小球前血管中对ANG II的剂量反应[10〜(-4)mol / l N〜G-硝基-L-精氨酸甲酯(L-NAME)]。 ANG II输注不会改变内皮型一氧化氮合酶(eNOS),caveolin-1和arginase-2的表达。 CAT1(0.3 8 +-0.07至0.73 +-0.12,P <0.05),CAT2(1.14 +-0.29至2.74 +-0.48),DDAH2(1.09 +-0.27至2.3 +-0.46)和精氨酸酶1(1.08在注入ANG II的大鼠中,+-0.17增加到1.82 +-0.22)。这通过氯沙坦治疗得以预防,氯沙坦治疗可降低eNOS的表达(对照组为0.97±0.26至0.37±0.11;注入ANG II的大鼠为0.8±0.16至0.36±0.1)和小窝蛋白1(2.49±在对照中为0.59至0.82±0.24,在注入ANG II的大鼠中为2.59±0.61至1.1±0.25。在对照组中,ANG II(10〜(-10)mol / l)使注入ANG II的动物的血管收缩至基线直径的53 +-15%和基线直径的90 +-5%(P <0.05)。 L-NAME进一步增强了基线直径的4±4%(P <0.05)。体内氯沙坦治疗使对10〜(-7)mol / l ANG II的反应使离体血管的反应性降低至基线的91 +-2%,而对照组为82 +-3%(P <0.05) ANG II输注引起的反应性。总之,肾阻力血管中的CAT1,CAT2,DDAH2和精氨酸酶1的表达是通过AT_1受体调节的。这一发现对于NOS和肾小球前血管功能的调节可能具有直接的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号